Hanley Jr. Michael Conick
Reporting owner on Forms 3, 4 and 5, CIK 1791413.
Hanley Jr. Michael Conick reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ANRO · Alto Neuroscience, Inc.CIK 1999480 | officer (CHIEF OPERATING OFFICER) | 1 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-18 | M exercised | +2,896 | $2.35 | 2,896 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-18 | S sold | -2,896 | $26.48 | 0 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Employee Stock Option (Right to Buy), derivative | 2026-11-18 | M exercised | -2,896 | $0 | 165,271 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-17 | M exercised | +2,104 | $2.35 | 2,104 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-17 | S sold | -2,104 | $26.816 | 0 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Employee Stock Option (Right to Buy), derivative | 2026-11-17 | M exercised | -2,104 | $0 | 168,167 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | M exercised | +17,729 | $2.35 | 17,729 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | M exercised | +44,271 | $2.35 | 62,000 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | M exercised | +8,000 | $2.35 | 70,000 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | S sold | -56,410 | $27.463 | 13,590 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | S sold | -10,895 | $28.4265 | 2,695 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Common Stock | 2026-11-16 | S sold | -2,695 | $29.0863 | 0 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Employee Stock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -17,729 | $0 | 170,271 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Employee Stock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -44,271 | $0 | 80,729 | Form 4 |
| ANRO · Alto Neuroscience, Inc.Employee Stock Option (Right to Buy), derivative | 2026-11-16 | M exercised | -8,000 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001791413-26-000002 | Alto Neuroscience, Inc. | 2026-11-18 |